{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:42:24Z","timestamp":1759970544556,"version":"build-2065373602"},"reference-count":58,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>Moesziomyces spp. (Pseudozyma) is a genus recognized as a new opportunistic human pathogen, causing systemic infections including premature neonates and adult patients. These fungi\u2019s natural resistance to caspofungin enables them to spread through vascular catheter colonization, making them a new etiological agent associated with fungal bloodstream infections (FBIs) and a significant contributor to high mortality rates. In this report, we present a case of fungemia caused by Moesziomyces aphidis species in a patient with medical history that revealed pancreatic cancer infiltrating the duodenum and bile ducts. During hospitalization, the M. aphidis was cultured twice from peripheral blood samples on Sabouraud agar. The strain was sensitive to amphotericin B and voriconazole. In vitro susceptibility testing revealed resistance to fluconazole, caspofungin, anidulafungin, and micafungin. Antifungal therapy with voriconazole resulted in the resolution of clinical symptoms associated with fungal infection. Related to M. aphidis fungemia, we reviewed a total of three cases in Europe published in the PubMed database between 2003 and 2024. To the best of our knowledge, this is the first case of M. aphidis FBI in Poland and the fourth case in an adult patient in Europe.<\/jats:p>","DOI":"10.3390\/jof11020095","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T08:48:23Z","timestamp":1737708503000},"page":"95","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Moesziomyces aphidis Bloodstream Infection in Oncologic Patient: First Report in Poland"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5647-2443","authenticated-orcid":false,"given":"Beata","family":"Sulik-Tyszka","sequence":"first","affiliation":[{"name":"Department of Microbiology, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland"},{"name":"Laboratory of Microbiology, University Center of Laboratory Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-8171","authenticated-orcid":false,"given":"Jolanta","family":"Ma\u0142yszko","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"P\u0119czu\u0142a","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Internal Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9269-3494","authenticated-orcid":false,"given":"Sylwia","family":"Jarzynka","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, University Center of Laboratory Medicine, Medical University of Warsaw, 02-091 Warsaw, Poland"},{"name":"Department of Medical Biology, Medical University of Warsaw, 02-091 Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Fang, W., Wu, J., Cheng, M., Zhu, X., Du, M., Chen, C., Liao, W., Zhi, K., and Pan, W. (2023). Diagnosis of invasive fungal infections: Challenges and recent developments. J. Biomed. Sci., 30.","DOI":"10.1186\/s12929-023-00926-2"},{"key":"ref_2","first-page":"271","article-title":"Invasive Fungal Infection","volume":"116","author":"Wagener","year":"2019","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"ref_5","unstructured":"Mora Carpio, A.L., and Climaco, A. (2024). Candidemia. StatPearls, StatPearls Publishing."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajem.2024.07.062","article-title":"Candida auris: A focused review for emergency clinicians","volume":"84","author":"Long","year":"2024","journal-title":"Am. J. Emerg. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S2666-5247(24)00042-9","article-title":"The WHO fungal priority pathogens list: A crucial reappraisal to review the prioritisation","volume":"5","author":"Casalini","year":"2024","journal-title":"Lancet Microbe"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1348-0421.2003.tb03385.x","article-title":"The first isolation of ustilaginomycetous anamorphic yeasts, Pseudozyma species, from patients\u2019 blood and a description of two new species: P. parantarctica and P. thailandica","volume":"47","author":"Sugita","year":"2003","journal-title":"Microbiol. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mmcr.2015.03.001","article-title":"Pseudozyma aphidis fungemia after abdominal surgery: First adult case","volume":"8","author":"Herb","year":"2015","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Liu, Y., Zou, Z., Hu, Z., Wang, W., and Xiong, J. (2019). Morphology and Molecular Analysis of Moesziomyces antarcticus Isolated from the Blood Samples of a Chinese Patient. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.00254"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.mmcr.2021.05.002","article-title":"Pseudozyma aphidis bloodstream infection in a patient with aggressive lymphoma and a history of intravenous drug use: Case report and review of the literature","volume":"33","author":"Maccaro","year":"2021","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101258","DOI":"10.1016\/j.mycmed.2022.101258","article-title":"Fungemia due to Moesziomyces aphidis (Pseudozyma aphidis) in a premature neonate. Challenges in species identification and antifungal susceptibility testing of rare yeasts","volume":"32","author":"Mpakosi","year":"2022","journal-title":"J. Mycol. Med."},{"key":"ref_13","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2022). Overview of Antifungal ECOFFs and Clinical Breakpoints for Yeasts, Moulds and Dermatophytes Using the EUCAST E.Def 7.3, E.Def 9.4 and E.Def 11.0 Procedures. Version 3, 2022, The European Committee on Antimicrobial Susceptibility Testing. Available online: http:\/\/www.eucast.org."},{"key":"ref_14","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2023). Overview of antifungal ECOFFs and Clinical Breakpoints for Yeasts, Moulds and Dermatophytes Using the EUCAST E.Def 7.4, E.Def 9.4 and E.Def 11.0 Procedures. Version 4.0, 2023, The European Committee on Antimicrobial Susceptibility Testing. Available online: http:\/\/www.eucast.org."},{"key":"ref_15","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2024). Breakpoint Tables for Interpretation of MICs for Antifungal Agents, Version 11.0, 2024, The European Committee on Antimicrobial Susceptibility Testing. Available online: http:\/\/www.eucast.org\/astoffungi\/clinicalbreakpointsforantifungals\/."},{"key":"ref_16","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (2024). The European Committee on Antimicrobial Susceptibility Testing. Overview of Antifungal ECOFFs and Clinical Breakpoints for Yeasts, Moulds and Dermatophytes Using the EUCAST E.Def 7.4, E.Def 9.4 and E.Def 11.0 Procedures. Version 5.0, 2024, The European Committee on Antimicrobial Susceptibility Testing. Available online: http:\/\/www.eucast.org."},{"key":"ref_17","unstructured":"(2024). EUCAST Guidance on Interpretation of MICs for Rare Yeast Without Breakpoints in Breakpoint Tables 2024-06-19 EUCAST, European Committee on Antimicrobial Susceptibility Testing."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e0208121","DOI":"10.1128\/aac.02081-21","article-title":"Factors Associated with Breakthrough Fungemia Caused by Candida, Trichosporon, or Fusarium Species in Patients with Hematological Disorders","volume":"66","author":"Kimura","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/CMR.00069-19","article-title":"Antifungal Susceptibility Testing: Current Approaches","volume":"33","author":"Berkow","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5598\/imafungus.2017.08.01.09","article-title":"Asexual and sexual morphs of Moesziomyces revisited","volume":"8","author":"Kruse","year":"2017","journal-title":"IMA Fungus"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/mmy\/myaa025","article-title":"Pseudozyma spp. human infections: A systematic review","volume":"59","author":"Telles","year":"2021","journal-title":"Med. Mycol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/myc.12435","article-title":"Pseudozyma aphidis fungaemia with invasive fungal pneumonia in a patient with acute myeloid leukaemia: Case report and literature review","volume":"59","author":"Joo","year":"2016","journal-title":"Mycoses"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1099\/jmm.0.47563-0","article-title":"Central venous catheter infection associated with Pseudozyma aphidis in a child with short gut syndrome","volume":"57","author":"Lin","year":"2008","journal-title":"J. Med. Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/myc.12098","article-title":"First neonatal case of fungaemia due to Pseudozyma aphidis and a global literature review","volume":"57","author":"Prakash","year":"2014","journal-title":"Mycoses"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1128\/JCM.01095-15","article-title":"First Case of Fungemia Due to Pseudozyma aphidis in a Pediatric Patient with Osteosarcoma in Latin America","volume":"53","author":"Orecchini","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.diagmicrobio.2012.09.010","article-title":"Pulmonary infection due to Pseudozyma aphidis in a patient with Burkitt lymphoma: First case report","volume":"75","author":"Parahym","year":"2013","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"100475","DOI":"10.1016\/j.ajoc.2019.100475","article-title":"Pseudozyma aphidis endophthalmitis post-cataract operation: Case discussion and management","volume":"15","author":"Voon","year":"2019","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-4632.2010.04814.x","article-title":"Isolation of both Pseudozyma aphidis and Nocardia otitidiscaviarum from a mycetoma on the leg","volume":"50","author":"Chen","year":"2011","journal-title":"Int. J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e12664","DOI":"10.1111\/tid.12664","article-title":"Pseudozyma and other non-Candida opportunistic yeast bloodstream infections in a large stem cell transplant center","volume":"19","author":"Pande","year":"2017","journal-title":"Transpl. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"bcr2014206369","DOI":"10.1136\/bcr-2014-206369","article-title":"Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review","volume":"2014","author":"Siddiqui","year":"2014","journal-title":"BMJ Case Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1111\/pace.14311","article-title":"Atypical pathogens associated with cardiac implantable electronic device infections","volume":"44","author":"Kohli","year":"2021","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Hu, F., Wang, C., Wang, P., Zhang, L., Jiang, Q., Al-Hatmi, A.M.S., Blechert, O., and Zhan, P. (2021). First Case of Subcutaneous Mycoses Caused by Dirkmeia churashimaensis and a Literature Review of Human Ustilaginales Infections. Front. Cell Infect. Microbiol., 11.","DOI":"10.3389\/fcimb.2021.711768"},{"key":"ref_33","first-page":"284","article-title":"First report of brain abscess associated with Pseudozyma species in a patient with astrocytoma","volume":"30","author":"Hwang","year":"2010","journal-title":"Korean J. Lab. Med."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Gil, E., Dur\u00e1n, M.T., Rodr\u00edguez-Tudela, J.L., Cuenca-Estrella, M., Cartelle, M., Molina, F., and Guerrero, A. (2003). Pseudozyma sp.: Colonizer of the respiratory tract in critical patients. Enferm. Infecc. Microbiol. Clin., 21.","DOI":"10.1016\/S0213-005X(03)72881-X"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/myc.12852","article-title":"The epidemiology of non-Candida yeast isolated from blood: The Asia Surveillance Study","volume":"62","author":"Lin","year":"2019","journal-title":"Mycoses"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/cid\/ciab726","article-title":"Coronavirus Disease 2019-Associated Mucormycosis: Risk Factors and Mechanisms of Disease","volume":"74","author":"Narayanan","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Corr\u00eaa-Junior, D., Andrade, I.B., Alves, V., Ara\u00fajo, G.R.S., and Frases, S. (2022). Clinical Challenges of Emerging and Re-Emerging Yeast Infections in the Context of the COVID-19 Pandemic. Microorganisms, 10.","DOI":"10.3390\/microorganisms10112223"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4244","DOI":"10.1007\/s12010-022-03979-5","article-title":"Human Fungal Infection, Immune Response, and Clinical Challenge-a Perspective During COVID-19 Pandemic","volume":"194","author":"Naveen","year":"2022","journal-title":"Appl. Biochem. Biotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2217\/fmb-2023-0261","article-title":"Severe mold fungal infections in critically ill patients with COVID-19","volume":"19","author":"Koulenti","year":"2024","journal-title":"Future Microbiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e13016","DOI":"10.1111\/pim.13016","article-title":"COVID-19 associated mucormycosis surge: A review on multi-pathway mechanisms","volume":"46","author":"Pourazizi","year":"2024","journal-title":"Parasite Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4103\/ijpm.ijpm_972_22","article-title":"Case report of a rare fungal infection Kodamaea ohmeri in COVID-19 patient in North Malaysian hospital","volume":"67","author":"Farooq","year":"2024","journal-title":"Indian. J. Pathol. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"100618","DOI":"10.1016\/j.mmcr.2023.100618","article-title":"Chaetomium globosum: Spotting a scarce saprophyte in bacterial-fungal co-infection of the sinuses in a post-COVID-19 patient","volume":"43","author":"Gade","year":"2024","journal-title":"Med. Mycol. Case Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e13761","DOI":"10.1111\/myc.13761","article-title":"Impact of COVID-19 on paracoccidioidomycosis. Which was the most influential: The pandemic or the virus?","volume":"67","author":"Giusiano","year":"2024","journal-title":"Mycoses"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Iturrieta-Gonz\u00e1lez, I., Giacaman, A., Godoy-Mart\u00ednez, P., Vega, F., Sep\u00falveda, M., Santos, C., Toledo, V., Rivera, G., Ortega, L., and San Mart\u00edn, A. (2022). Penicillium digitatum, First Clinical Report in Chile: Fungal Co-Infection in COVID-19 Patient. J. Fungi, 8.","DOI":"10.3390\/jof8090961"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11046-022-00637-6","article-title":"Fungal Bloodstream Co-infection by Trichosporon asahii in a COVID-19 Critical Patient: Case Report and Literature Review","volume":"187","author":"Benelli","year":"2022","journal-title":"Mycopathologia"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/1469-0691.12360","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections","volume":"20","author":"Arendrup","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1016\/S1473-3099(21)00203-6","article-title":"Global guideline for the diagnosis and management of rare yeast infections: An initiative of the ECMM in cooperation with ISHAM and ASM","volume":"21","author":"Chen","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1469-0691.12569","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Fungal Infection Study Group (EFISG) and European Confederation of Medical Mycology (ECMM) 2013 joint guidelines on diagnosis and management of rare and emerging fungal diseases","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: Diagnostic procedures","volume":"18","author":"Verweij","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Robert, M.G., Cornet, M., Hennebique, A., Rasamoelina, T., Caspar, Y., Pond\u00e9rand, L., Bidart, M., Durand, H., Jacquet, M., and Garnaud, C. (2021). MALDI-TOF MS in a Medical Mycology Laboratory: On Stage and Backstage. Microorganisms, 9.","DOI":"10.3390\/microorganisms9061283"},{"key":"ref_51","first-page":"32","article-title":"Geotrichosis: Fungemia in a patient with acute lymphoblastic leukemia","volume":"43","author":"Reyes","year":"2023","journal-title":"Biomedica"},{"key":"ref_52","first-page":"e51147","article-title":"Fungemia Due to Saprochaete capitata in a Non-Neutropenic Critically Ill Patient","volume":"15","author":"Mawad","year":"2023","journal-title":"Cureus"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Ioannou, P., Baliou, S., and Kofteridis, D.P. (2024). Fungemia by Wickerhamomyces anomalus-A Narrative Review. Pathogens, 13.","DOI":"10.3390\/pathogens13030269"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Zhu, H.-H., Liu, M.-M., Boekhout, T., and Wang, Q.-M. (2024). Improvement of a MALDI-TOF database for the reliable identification of Candidozyma auris (formally Candida auris) and related species. Microbiol. Spectr., 13.","DOI":"10.1128\/spectrum.01444-24"},{"key":"ref_55","unstructured":"Cobo, F. (2018). Chapter Fourteen\u2014Use of MALDI-TOF Mass Spectrometry in Fungal Diagnosis. The Use of Mass Spectrometry Technology (MALDI-TOF) in Clinical Microbiology, Academic Press."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/j.1469-0691.2010.03360.x","article-title":"A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units","volume":"17","author":"Montravers","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5604\/01.3001.0004.1524","article-title":"A review of laboratory methods for diagnosis of invasive fungal infections","volume":"51","year":"2015","journal-title":"J. Lab. Diagn."},{"key":"ref_58","first-page":"157","article-title":"Epidemiological analysis and evaluation of in vitro susceptibility to micafungin of clinical strains of Candida spp. causing fungaemia in patients hospitalised in intensive care unit","volume":"8","year":"2017","journal-title":"Forum Zaka\u017ce\u0144"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/2\/95\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:35:32Z","timestamp":1759919732000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/11\/2\/95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["jof11020095"],"URL":"https:\/\/doi.org\/10.3390\/jof11020095","relation":{},"ISSN":["2309-608X"],"issn-type":[{"type":"electronic","value":"2309-608X"}],"subject":[],"published":{"date-parts":[[2025,1,24]]}}}